explore -WSS

explore

author：comprehensive 2025-09-30 19:27:07 - browse：144

When is negative data positive enough? Who gets credit for scientific breakthroughs? And wasn’t biotech supposed to bounce back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain the story of Svetlana Mojsov, a chemist who played a vital role in the discovery of GLP-1 who has spent decades fighting for proper recognition. We also discuss the latest news in the life sciences, including the FDA hearing on a BrainStorm Cell Therapeutics’ polarizing ALS treatment, the end of the road for a once-vaunted drug developer, and the sorry state of biotech stocks.

For more on what we cover, here’s the Mojsov story; here’s the latest on BrainStorm; here’s the news on Intercept Pharmaceuticals; here’s more on the biotech market; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medical records are filled with copy
Next article： PBMs drew scrutiny in House hearing — and so did pharma

knowledge

WSS

Medicare to pay more for cardiac rehab in hospital outpatient clinics

What happened to the House vote on health price transparency?

Grad students accuse University of California of wage theft

Senate bill would ban some hospital facility fees

David Liu startup to focus on CRISPR delivery

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

focus

explore

leisure time

DIEP, the 'gold standard' of breast reconstruction, is under threat

'A game

Novavax promises a turnaround & Lilly roils the obesity market

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Apple is now the first public company to be valued at $3 trillion

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Bright Health sells Medicare Advantage business to Molina

Hormonal contraceptives don’t actually treat endometriosis

As demand for Covid shots wanes, Moderna seeks its next success

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

focus

Neurocrine congenital adrenal hyperplasia trial succeeds

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Grad students accuse University of California of wage theft

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Extensive review finds private equity owners jack up cost of care

How a Boston hospital is priming medical residents to use GPT

Wikipedia

knowledge

entertainment

leisure time